Exane Derivatives’s XPeng XPEV Stock Holding History
Bought
Maintained
Sold
Other funds holding XPEV
PCM
AMH
AG
Exane Derivatives's XPEV Position: Q2 2022 in Review
Exane Derivatives sold out of XPeng (XPEV) in Q2 2022, closing a stake of 7,468 shares — an estimated $206K sold.
Exane Derivatives first reported a position in XPEV in Q4 2020 and held it in 5 quarters. The position peaked at $997K in Q4 2020. 304 funds tracked by Wall St. Rank hold XPEV as of Q2 2022.
- Exane Derivatives reported no remaining XPeng position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 7,468 XPeng shares in Q2 2022, an estimated $206K.
- Exane Derivatives first reported a position in XPeng in Q4 2020 and held it in 5 quarters.
- Exane Derivatives's XPeng position peaked at $997K in Q4 2020.
- 304 funds tracked by Wall St. Rank held XPeng as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.